FDA , National Cancer Institute y el Grupo Oncologico Infantil siguen de valedores de la Fase II del Yondelis en Niñ@s ... ¡¡ poco toxico sera !! ¿No?

... cuando les inyectan Yondelis en vena a sus Hij@s ...

Yondelis in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors .

This study is currently recruiting participants.

Verified by National Cancer Institute (NCI), July 2009

Sponsors and Collaborators: Children's Oncology Group
National Cancer Institute (NCI)

Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00070109